Science correspondent Nicola Davis investigates the strange story of Tam O’Braan and his attempts to grow tea in Scotland.
In episode one, Nicola looks back on her first meeting with Tam while working on a feature about tea plantations in the UK. He was selling his award-winning Scottish-grown tea to some of the UK’s finest hotels, but something didn’t quite add up. And Nicola wasn’t the only person taking an interest in his story
What’s next for cryptocurrency? The question that keeps crypto enthusiasts, analysts, and even financial students up at night. While giants like Bitcoin and Ethereum grab headlines, two coins have been sparking buzz for different reasons. XRP is fighting to reclaim its glory, while MoonBull ignites as the next 1000x crypto, stirring serious excitement. TXRP is trading at $2.63 today. Its 24-hour trading volume is $4,469,450,489, up 9.29% from the previous week.
The big question is simple yet vital: Will XRP rise high in 2025 or face downside fears? With investors watching closely, this could be the turning point that reshapes both coins’ futures.
Now here’s where the excitement skyrockets: MoonBull ignites as the next 1000x crypto, powering its ecosystem with massive staking and smart referral features. At Stage 10, MoonBull ($MOBU) unlocks an incredible 95% yearly staking reward, drawn from a 14.68 billion $MOBU pool, with daily rewards, zero minimum staking, and just a two-month lock-in. But the real kicker is the referral system: share your code, your invitee gets 15% more tokens, and you earn 15% instantly.
MoonBull ignites as the next 1000x crypto, offering 95% yearly staking from a 14.68B $MOBU pool with daily rewards and no lock-in. Referrers earn 15%, buyers get 15% extra tokens, plus monthly USDC bonuses of 10% and 5% for top leaders. Backed by an 8.05B $MOBU allocation, MoonBull delivers real rewards, real community, and unstoppable growth for early believers.
MoonBull ignites as the next 1000x crypto, and the buzz is electric. The MoonBull presale is live right now, sitting at Stage 5 with a current price of $0.00006584, over $500K raised, and 1,500+ token holders already in. The current ROI is jaw-dropping,9,256% from Stage 5 to the listing price of $0.00616. Early entrants have already bagged a 163.36% ROI, and prices are climbing 27.40% per stage through Stage 22, then 20.38% through Stage 23.
Investing $600 at Stage 5 gets you 9,113,001.22 tokens, which could turn into $56,136.09 at listing. That’s the kind of number that turns heads and triggers FOMO. The clock’s ticking, every stage makes it pricier to join, and this train’s leaving the station fast.
So, what’s the XRP price prediction for 2025? Forecasts vary, but here’s the gist. If the crypto market stabilizes, Ripple wins further legal clarity, and institutions embrace its payment network, XRP could shoot toward the $4 -$6 range. CoinCentral even mentions extreme targets near $9.60 or $33 if sentiment turns wildly bullish. But if regulations tighten or investor confidence wanes, XRP might hover around $2 or lower.
Given the current XRP price, sitting below $1, even a conservative rally to $4 would mean substantial gains. Still, this coin’s story depends on what happens outside the charts, global adoption, regulatory wins, and macroeconomic flows. Analysts say that if Ripple lands new partnerships with payment networks or banks, XRP could see a bullish domino effect across the market. In short, 2025 could be the year XRP either soars or sinks. Investors need to watch the fundamentals like hawks.
XRP isn’t your average meme coin chasing trends. It’s a digital asset designed to enable faster, cheaper cross-border payments. Ripple Labs, the company behind it, has been working to integrate its ledger with banks and fintech players. That’s given XRP a more “real-world” purpose than most tokens. But crypto markets are as unpredictable as cats on roller skates; one move and everything can flip.
Analysts recently suggested that if XRP can hold above $1.91, it might climb toward the $4.43- $7.90 range. Others, like Nasdaq, warn of possible dips if momentum fades. That tension keeps traders on their toes and investors glued to charts.
Right now, the XRP price reflects cautious optimism. Volume remains high, and with a solid 7-day surge, bulls seem to be waking up. Yet skeptics argue that whales are waiting for clearer regulatory signals before returning to the market.
The crypto market’s memory might be short, but XRP’s journey has been wild. From explosive rallies to gut-wrenching crashes, it’s seen both sides of the coin. Historical trends show that XRP tends to move in strong waves. When it rallies, it runs, but when it drops, it tumbles like penguins on ice.
According to CoinCentral, some optimistic models suggest XRP could hit $5 to $15 by late 2025 if the market turns bullish and liquidity flows in. CoinDCX paints a more cautious picture, projecting that XRP will trade between $2.50 and $3.50 during the same period. Meanwhile, Brave New Coin analysts warn that a “death cross” pattern could push the XRP crypto price toward $1.93 before any rebound.
In plain English: the upside potential is there, but so is the downside. Like a game of poker, timing and patience matter as much as the hand you’re dealt.
The crypto market never sleeps, and neither should investors watching it. XRP stands as a veteran trying to reclaim its throne, while MoonBull ignites as the next 1000x crypto, offering something new and daring. For those weighing risk versus reward, XRP might be the “steady bet” with long-term potential, and MoonBull the thrilling play for early adopters chasing high returns.
As 2025 approaches, XRP’s next move could depend on adoption and regulation. But one thing’s clear, the world of crypto isn’t slowing down. Whether you’re analyzing charts or joining the $MOBU presale, this is the time to stay alert, act fast, and ride the next big wave.
For More Information:
Website: Visit the Official MOBU Website
Telegram: Join the MOBU Telegram Channel
Twitter: Follow MOBU ON X (Formerly Twitter)
A presale token offering 9,000%+ potential ROI from early joiners, like MoonBull’s current stage, tops that chart.
The best new crypto is one that combines high APY staking, a structured presale, and active community engagement — exactly what MoonBull offers.
A well-known digital asset with strong banking ties and new partnerships may see a rebound; XRP fits that narrative.
Presales with rising stage prices, transparent tokenomics, and referral systems often become breakout plays. MoonBull is one to watch.
Tokens offering high staking rewards with flexible lock-in periods, like MoonBull’s 95% APY staking, rank among the best for 2025.
Staking: Earning passive rewards by locking crypto tokens in a smart contract.
Presale: The early phase before a public listing, when investors buy at discounted rates.
ROI: Return on Investment, a measure of profit compared to the initial cost.
Whales: Large crypto holders capable of moving markets.
APY: Annual Percentage Yield showing yearly return from staking.
Next 1000x rypto, MoonBull, MoonBull presale, $MOBU presale, $MOBU, XRP price, XRP coin price prediction, XRP price today, top crypto to buy, best crypto to buy now
This article breaks down XRP’s live market action, its recent 11.32% rise, and the XRP price prediction for 2025, ranging from cautious $2.50 targets to bullish $9+ forecasts. It explains how investor sentiment, regulatory clarity, and institutional adoption will shape its fate. In contrast, it spotlights how MoonBull is poised to become the next 1000x crypto, detailing its explosive presale, 95% APY staking, and powerful referral system. For anyone scanning for the top crypto to buy or the best crypto to buy now, both XRP and MoonBull deliver lessons in opportunity, timing, and growth.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Cryptocurrency investments carry risks. Always conduct independent research before investing in any project.
The (Brent) price settled high during its last intraday trading, attempting to breach the current resistance level at $65.55, this resistance represents our expected target in our previous analysis, taking advantage of the dynamic support that is represented by its trading above EMA50, and under the dominance of strong bullish corrective wave on the short-term basis, noticing that the relative strength indicators have reached exaggerated oversold levels compared to the price move, providing big chance for forming positive divergence, intensifying the positive momentum in its upcoming trading.
Get high-accuracy trading signals delivered directly to your Telegram. Subscribe to specialized packages tailored for the world’s top markets:
Full VIP signals performance report for 13-17, October 2025:
View Full Performance Report Telegram (https://t.me/besttradingsignalstocksbot?start=p88d632b0-66dd-11f0-a948-13815052d5ae)
Avinash Clarke, assistant secretary of the Complementary and Over-The-Counter Medicine at TGA, said the above during a keynote address at the Natural Products Futures Forum organized by the Southern Cross University’s National Centre for Naturopathic Medicine on Oct 23.
Clarke was giving a presentation titled “Australian Regulation of Complementary Medicines: An update from the TGA”.
There are currently 778 permissible indications under the listed medicines framework, which could be further increased.
Health supplements are regulated as listed medicines, assessed listed medicines, or registered medicines in Australia.
Listed medicines do not have to undergo premarket evaluation and can only use permitted ingredients and permitted indications, and they must hold evidence at the time of listing to support its indications. In contrast, assessed listed medicines have to undergo premarket evaluation for efficacy, and can use at least one intermediate level indication on top of permitted indications.
“We want to focus on getting out clear guidance, for example, what a delegate looks at when assessing applications for new permitted indications,” he said during his speech.
This could be in the form of a webinar and part of an ongoing conversation with the industry.
“It is also part of ongoing conversations around how we can support permitted indications where appropriate. For listed medicines, they cannot be too strong in indications, such as curing a serious disease,” he said.
Permitted indications can focus on health maintenance, health enhancement, prevention of a dietary deficiency, and a non-serious form of a disease, ailment, defect or injury.
Examples include maintain intestinal good flora, enhance healthy digestion, and relieve digestive discomfort.
At the moment, the TGA does not evaluate evidence to support the use of a new proposed indication for a listed medicine at the time of application, and in general, there is no requirement to submit supporting information.
However, the TGA will assess whether the indication meets the criteria for permitted indications and the permitted indication assessment tool was already developed to help applicants determine if a proposed indication is suitable to be included in the permitted indication list.
The ongoing plans in reducing the Recommended Daily Dose (RDD) of vitamin B6 sold in retail to 50mg in response to increased reports of peripheral neuropathy, will also see a decision finalized possibly in next month.
The are also plans around the remaking of therapeutic labelling rules, including TGO 91 and TGO 92 which are standard for labels of prescription and related medicines, and standards for labels of non-prescription medicines respectively.
Complementary medicines would need to comply with TGO 92.
“The other thing that will keep us busy is the remaking of a couple of therapeutic labelling rules, TGO 91 and TGO 92. This will be quite a comprehensive consultation on a range of topics, and we are hoping to get that out by the end of the year…That’s a priority for us,” said Clarke.
Solana price is regaining bullish momentum as short positions vanish and price strength builds above key support, signaling potential continuation towards higher resistance levels.
Solana’s bulls are back in action, driving renewed optimism across the market. The token’s steady climb from $190 to $205 has erased much of the earlier fear, leaving short sellers with little room to maneuver.
Market data shows that short positions on Solana have dropped sharply, with liquidation heatmaps revealing a clear absence of sell-side pressure. The steady climb from the $190 to $205 range highlights that bears are running out of room, while liquidity continues to concentrate higher. CW8900’s observation confirms that shorts are nearly exhausted, giving buyers the upper hand in maintaining upward pressure.
Solana’s steady climb from $190 to $205 highlights growing bullish dominance as shorts rapidly vanish. Source: CW8900 via X
This pattern often marks the transition towards a sustained bullish phase. With open interest leaning long and volume spikes accompanying each breakout, Solana’s current positioning suggests that the path of least resistance is now upward. Any pullback into the $198 to $200 support zone may simply serve as a springboard for renewed buying momentum.
The latest 4-hour chart indicates Solana price breaking above its Ichimoku Cloud, a strong technical signal that often precedes trend continuation. Price is now holding firmly above both the conversion and base lines, suggesting clear bullish dominance. The cloud’s leading span is widening upward, a textbook confirmation of positive market structure.
Solana breaks above the Ichimoku Cloud, signaling renewed bullish strength with eyes set on the $230 target. Source: AliseeisW via X
As AliseeisW highlighted, the next resistance stands around $230, aligning with prior swing highs. If price maintains this breakout and continues closing above $198 to $200, it would validate the bullish signal and likely extend towards $230 to $238 in the short term.
TraderSZ’s long-term Solana outlook remains unchanged, still firmly bullish. The weekly structure reveals consistent higher lows since early 2023, with the price currently rebounding from a key rising trendline. The chart identifies major resistance levels at $300, $390, and $520, suggesting a steady stair-step progression if momentum persists.
Solana’s long-term trend structure mirrors its 2021 accumulation phase, hinting at a potential run toward $300–$390. Source: TraderSZ via X
This long-term pattern resembles Solana’s 2021 accumulation phase, where breakouts led to exponential follow-through. As long as price remains above the $180 to $190 zone, macro bias stays bullish. The next expansion wave could be targeting the $300 to $390 range before any significant corrective phase.
Following a clean track-line test, Solana’s structure now looks increasingly constructive. ShardiB2’s chart shows price reclaiming the 50-day and 200-day moving averages with strength, confirming renewed bullish intent. RSI momentum sits in the mid-60s, hinting that room still exists for another upward leg before overbought conditions emerge.
Solana reclaims key moving averages, with momentum building toward short-term resistance at $216 and $227. Source: ShardiB2 via X
Immediate resistance is seen around $216 and $227, which mark the next major upside checkpoints. A daily close above $205 would confirm continuation, setting the stage for a run toward those targets. For now, Solana’s trend remains clearly bullish, with higher lows and strong demand supporting each move higher.
Across multiple timeframes, Solana’s outlook continues to strengthen. The fading short positions, breakout above the Ichimoku Cloud, and clear macro uptrend all align toward a consistent bullish narrative.
For short-term participants, maintaining the $198 to $200 support is crucial, while mid-term participants may eye towards $230 to $250 as likely continuation zones. If macro momentum continues, Solana could retest $300–$390 before year-end, confirming its leadership among high-cap altcoins.
The Pound to US Dollar (GBP/USD) exchange rate firmed at the start of the week as softer US inflation data fuelled expectations for aggressive Federal Reserve rate cuts and lifted risk sentiment.
DAILY RECAP:
The US Dollar (USD) lost traction on Monday as markets digested the implications of last Friday’s softer US CPI report.
Headline inflation eased more than expected, reinforcing the view that price pressures are cooling and boosting market confidence that the Federal Reserve could cut rates by up to 50 basis points before year-end.
This dovish shift in expectations weighed on USD across the board, with the currency also pressured by a broad risk-on tone after reports of progress in US-China trade talks.
Meanwhile, the Pound (GBP) traded in tight ranges, with little domestic data to provide direction.
Traders focused on the afternoon’s CBI distributive trades survey, expected to show another dip in retail sales activity — potentially signalling softer consumer demand.
Overall, Sterling’s performance on Monday reflected its rising sensitivity to shifts in global risk appetite rather than homegrown fundamentals.
All eyes now turn to Wednesday’s Federal Reserve policy meeting.
Markets widely expect a 25bps rate cut, though speculation has grown over a larger 50bps move following last week’s inflation data.
If the Fed delivers a bigger cut or signals further easing ahead, the Dollar could slide sharply.
Conversely, a cautious tone or smaller-than-expected move might prompt a USD rebound.
With the UK data calendar quiet, GBP/USD direction will hinge primarily on the Fed’s decision and the accompanying guidance.
Continued risk-on sentiment would also favour the Pound, while any souring in global mood could see Sterling retrace gains.
IF YOU’RE ONE of the nearly 120 million adults with hypertension—or if you want to avoid becoming one of them—a few dietary tweaks (plus regular exercise and shedding excess belly fat) could make a big difference.
Notice how we said a few tweaks. You don’t have to overhaul your whole diet—that’s a recipe for failure. Instead, think about it as upgrading your diet to add some more plant-based foods, like fruits, vegetables, nuts, legumes, and grains. A study review in the Journal of Hypertension showed that people who ate plant-rich diets, such as the Dietary Approaches to Stop Hypertension (DASH) diet, Nordic diet, or Mediterranean diet, had lower blood pressures on average than those who didn’t.
Yes, you can still have animal foods like meat and dairy. The idea is just to add more plants into the mix. Plant foods tend to be high in nutrients like potassium, magnesium, and others that help counterbalance sodium, a mineral many Americans overeat, to keep blood pressure in check.
“Think of the relationship between sodium and these other minerals kind of like as a pulley system,” says Roberta Anding, MS, RD/LD, a dietitian and assistant professor at Baylor College of Medicine. “When you think about high-sodium foods, usually things that are really high in sodium are low in these other nutrients, and what you’re trying to do is balance these out, so it’s not like you can never have salt or anything that’s got sodium in it, but the question is what is on the other side of the pulley system.”
Generally this means staying away from ultra-processed foods, which tend to be sky-high in sodium. You’ll also want to add some high-potassium foods in the mix as well. Here are some examples of some foods you’ll want to add to your diet to help you keep your BP in the safe zone.
Salads can help you lower your blood pressure and protect your heart, thanks in part to a compound called nitrate, which helps blood vessels open and close.
In a study published in the European Journal of Epidemiology, people who ate the most nitrate-rich vegetables had lower systolic blood pressures, by about three points on average, than people who ate the least. Then, over the following 23 years, people who consumed about 60 milligrams of nitrate from vegetables per day had a lower risk of developing cardiovascular disease than those who ate less. Lettuce was the top nitrate-rich vegetable in participants’ diets. The researchers say about a cup of green leafy vegetables per day could be enough to reduce cardiovascular disease risk.
Need some inspiration to make a delicious salad you would actually want to eat? Check out four salads these chefs recommend.
Beet juice is Anding’s favorite BP-reducing food. The reason: It’s rich in blood-vessel-friendly nitrates, and it’s easy to incorporate into your diet even if you hate the taste of vegetables. One study of nitrate-rich beetroot juice suggested the drink can lower people’s blood pressure after 90 days.
Anding has helped many collegiate and professional athletes keep their BPs in check by showing them how to work beet juice into their daily routines. And now you can too. You can down a one-ounce serving of beet juice like a shot or mix it into your favorite fruit or vegetable smoothie. If you like beets in their natural form, roast three to five beets as a side dish or accompaniment to your favorite salad. There’s also beetroot powder supplements for people also looking to use it as a pre-workout energy booster.
These green nuts could help you keep your BP in the clear. In a study review published in the British Journal of Nutrition, researchers found that regular pistachio consumption is associated with a systolic blood pressure reduction of about two points. Pistachios and other nuts are rich in magnesium, fats, fiber, and polyphenols that might all have beneficial effects on blood pressure, says Anding. She recommends crushing pistachios and using them in place of breadcrumbs or croutons. “Those are probably the two ways I use it, as a coating for either chicken or fish or in salads,” she says.
Another nut worth cracking? The cashew.
A study review published in the journal Complementary Therapies in Medicine showed that people who regularly ate cashews had systolic blood pressures about three points lower than those who did not. The fatty acids in cashews might beneficially affect baroreflex sensitivity, one of your body’s mechanisms for regulating blood pressure, the researchers say. Cashews are also rich in arginine, which your body uses to make nitric oxide to expand and contract your blood vessels.
Of course, good old H2O can help you regulate your BP. In a study published in the journal Nutrients, healthy adults who drank an extra 550 milliliters of water in the morning and at bedtime reduced their systolic blood pressure by about six points within 12 weeks. Now let’s get down to the why.
The extra hydration might have helped study participants in multiple ways, such as improving their kidney function to help them clear excess sodium and water, changing their secretion of hormones involved in raising BP, or decreasing resistance in their circulatory system, the researchers say.
Though there is one important caveat. If you already have hypertension and take medicine to control it, talk with your doctor before changing your fluid intake. This is especially important if you take a diuretic, which works by helping your body clear out excess water and sodium, says Anding.
Sipping tea could help you calm your mind and tame your blood pressure. A study review published in the journal Complementary Therapies in Medicine suggests that drinking about three to four cups of tea daily, especially green tea, could reduce systolic blood pressure by about 3.5 points and diastolic blood pressure by about a point. Antioxidants in tea might lower blood pressure in many ways, such as increasing the bioavailability of nitric oxide to dilate blood vessels, suppressing a hormone system known to trigger blood pressure increases, and reducing inflammation, the researchers say.
You can upgrade your daily breakfast with less than a half cup of hot cereal. In a study published in the journal Nutrition, Metabolism and Cardiovascular Diseases, people with hypertension who consumed 30 grams of fiber-rich oat bran daily reduced their systolic blood pressure by an average of 15 points and their diastolic blood pressure by an average of 10 points within 30 days. The bran eaters then needed less BP-lowering medication than people in the control group. One reason: The bran diet induced a beneficial shift in gut bacteria toward species that produce short-chain fatty acids that might activate receptors in the kidneys and blood vessels in a way that benefits blood pressure regulation.
You might have to deal with some gas later, but there’s a reason everyone says beans are good for your heart. In a study published in the journal Nutrients, people who ate 55 to 70 grams of legumes (about one-third of a cup of cooked lentils or beans) per day were 43 percent less likely to develop hypertension over nearly four years than people who ate less. Legumes tend to be high in potassium plus filling fiber and protein, says Anding. Pair them with other BP-reducing foods for a healthy meal; for example, you can add nuts to lentil curries for creaminess and crunch, she recommends.
Potato lovers, do we have some good news for you. In a study published in the journal Nutrients, people who added 1,000 milligrams of potassium per day from baked or boiled potatoes (that’s about a potato and a half) to their daily diets reduced their systolic blood pressure by about three more points than people on a control diet within just 17 days. Potatoes are rich in potassium and may help reduce sodium retention, the researchers say.
Sadly, not all potato dishes are created equal. In the same study, people fed French Fries didn’t reap the same blood pressure benefits.
Fatty fish, such as bluefin tuna and mackerel, are a must to include in your next meal. These are rich in omega-3 fatty acids, which you may have heard is great for the brain. And another added bonus is that it can help lower your blood pressure. Here’s how.
Omega-3s help transfer sodium, potassium, phosphorus, and fluids into your cells and aid your body’s regulation of an important hormone. “Omega-3 sensitizes your body to your own insulin,” says Anding. “When you make your own insulin in the right amount, things go well; when you make too much insulin, you can have the retention of fluid and sodium, which contribute to high blood pressure.”
The American Heart Association recommends eating fish at least twice a week, like this chef-approved salmon dish.
Julie Stewart is a writer and content strategist whose work has also appeared in Health, and Women’s Health, Everyday Health, Vice, and Shape.
Binance coin price analysis by Coinidol.com: the BNB price is declining, although it remains above the $1,000 support and below the $1,200 resistance.
The cryptocurrency has twice reached a high of $1,355 before being rejected. Since October 17, the price has been confined between the moving average lines. The altcoin will trend if either the 21-day SMA resistance or the 50-day SMA support is breached.
Today, the price is approaching the 21-day SMA resistance. If the 21-day SMA is broken, the price will return to its previous high of $1,355. However, if BNB loses the 50-day SMA support, it will fall towards the $891 support. BNB is currently trading at $1,126.
The 21-day SMA resistance and the 50-day SMA support have limited price movement. The rising slope of the moving average lines indicates a previous uptrend. On the 4-hour chart, the price bars are above the horizontal moving average. Price movement has remained steady due to the presence of Doji candlesticks.
BNB/USD daily chart – September 26, 2025
BNB remains in a sideways trend, above the $1,040 support but below the $1,160 resistance. Today, the price is rising towards $1,160. The latest peak previously resisted upward movement. The signal remains range-bound as the price is situated between the moving average lines on the daily chart.
BNB/USD 4-hour chart – September 26, 2025
Disclaimer. This analysis and forecast are the personal opinions of the author. The data provided is collected by the author and is not sponsored by any company or token developer. This is not a recommendation to buy or sell cryptocurrency and should not be viewed as an endorsement by Coinidol.com. Readers should do their research before investing in funds.
The US Dollar to Japanese Yen (USD/JPY) exchange rate is trading near ¥152.86, down 0.14% on the day after touching resistance around 153.27 last week.
Rabobank says the week ahead could be pivotal for the yen, with markets watching both the Bank of Japan’s October 30 policy meeting and Prime Minister Takaichi’s first in-person meeting with US President Trump.
“The market’s implied path for policy now suggests only 20 bps of tightening over three months,” Rabobank noted, “reflecting a loss of confidence in the BoJ’s ability to deliver another 25-bps hike before year-end.”
The bank highlighted that the yen has been the worst-performing G10 currency so far this month, losing over 3% against the US dollar.
“We see scope for the JPY to recover some ground versus the USD on the assumption that BoJ rates can be raised again by the turn of the year,” the bank said.
“This in turn assumes that Governor Ueda underscores the BoJ’s hawkish bias at this week’s policy meeting.”
Rabobank forecasts USD/JPY at 147 on a three-month view, adding that “recent highs around 153.27 are likely to provide resistance,” and that it would favour selling rallies ahead of the BoJ decision.
On the political front, the bank said Takaichi’s meeting with Trump “will be an early test of her ability to maintain Japan’s alliance with Washington” and that she is unlikely to advocate a weaker yen policy given the sensitivity of imported inflation.
Current USD/JPY rate: ¥152.86. More Dollar-Yen forecasts.
A flurry of analyst notes today puts fresh focus on Cardano price prediction ranges while hinting that a $0.11 rival could sprint to $1 first. That rival is Remittix, a PayFi network priced at $0.1166, where more than 40,000 investors have joined in recent months. We will cover the Cardano price prediction setup first, then explain why some experts think Remittix could outpace ADA on the road to $1.
Source: Lingrid
The Cardano price prediction narrative remains cautious. ADA is trading inside a descending channel after a sharp rejection at the upper boundary. Bulls also failed to sustain momentum near $0.85, setting up lower highs and lower lows. On this basis, several traders say the Cardano price prediction path favors a move toward the $0.55 target zone unless momentum flips.
The $1 race is not only about charts. Utility and distribution matter. Analysts who are cautious on ADA’s near-term technicals are highlighting new payment-focused projects with low gas fees, simple user flows, and strong listings. That is why the Cardano price prediction debate now includes a serious look at alternatives that could climb faster from a lower base.
Remittix is a PayFi DeFi project designed for fast, low-cost cross-border transfers. The wallet beta has launched, the team is fully CertiK-verified, and it is ranked #1 for Pre-Launch Tokens on Skynet. Remittix has raised over $27.5M with more than 679M tokens sold, and listings on BitMart and LBank are confirmed, with another major CEX reveal on the way. You can currently buy the RTX token at $0.1166. For readers comparing momentum plays, this profile is why some believe it could reach $1 before ADA.
Why Remittix is tipped to pass the $1 mark soon:
A conservative Cardano price prediction still targets $0.55 unless ADA breaks the channel to the upside. At the same time, Remittix is making the case for the ‘best crypto project 2025’ short list with centralized exchanges access, a path to decentralized exchange liquidity, and a strong payments focus. For those scouting upcoming crypto projects, Remittix offers utility plus network-driven growth. If it fits your plan, explore RTX while the Cardano price prediction story waits for confirmation.
Disclaimer: The content above is presented for informational purposes as a paid advertisement. The Tribune does not take responsibility for the accuracy, validity, or reliability of the claims, offers, or information provided by the advertiser. Readers are advised to conduct their own independent research and exercise due diligence before making any decisions based on its contents and not go by mode and source of publication. Investments in cryptocurrencies are subject to high market risks and volatility; readers should seek professional advice before investing.
